![](https://www.goodventures.org/wp-content/uploads/2023/02/low-endocytosis-2048x1273-1-1024x637.jpeg)
Open Philanthropy recommended a grant of $600,000 over three years to Purdue University to support a phase III trial of imatinib, a drug previously approved to treat leukemia, to test its efficacy against drug-resistant strains of malaria in Vietnam. This research will be coordinated by Professor Philip Low, who previously organized a successful phase II trial of imatinib.
This falls within Open Philanthropy’s focus area of scientific research, specifically within their interest in advancing human health and wellbeing.